Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Bosman

Showing results (151-160 of 154) with videos related to

Pageof 16
Sort By:
You have reached the last page of results.This site can display upto 154 results.
Infection and Immunity|June 1, 1997
Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicityR Lucas, B Echtenacher, E Sablon, et al.
The Journal of Biological Chemistry|March 27, 1999
Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptorsG Wuytens, K Verschueren, J P de Winter, et al.
Acta Gastro-Enterologica Belgica|October 7, 2000
Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 proteinG Maertens, S Priem, A Ducatteeuw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07D Helbling, G Bodoky, O Gautschi, et al.
Pageof 16

Showing results (151-160 of 154) with videos related to

Sort By:
Pageof 16
You have reached the last page of results.This site can display upto 154 results.
Infection and Immunity|June 1, 1997
Generation of a mouse tumor necrosis factor mutant with antiperitonitis and desensitization activities comparable to those of the wild type but with reduced systemic toxicityR Lucas, B Echtenacher, E Sablon, et al.
The Journal of Biological Chemistry|March 27, 1999
Identification of two amino acids in activin A that are important for biological activity and binding to the activin type II receptorsG Wuytens, K Verschueren, J P de Winter, et al.
Acta Gastro-Enterologica Belgica|October 7, 2000
Improvement of chronic active hepatitis C in chronically infected chimpanzees after therapeutic vaccination with the HCV E1 proteinG Maertens, S Priem, A Ducatteeuw, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 10, 2012
Neoadjuvant chemoradiotherapy with or without panitumumab in patients with wild-type KRAS, locally advanced rectal cancer (LARC): a randomized, multicenter, phase II trial SAKK 41/07D Helbling, G Bodoky, O Gautschi, et al.
Pageof 16